BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BNT351 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BNT351\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07392372-997@assetmemo.bio
DTSTAMP:20261121T004538Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:BNT351: Phase 1 readout est. (NCT07392372)
DESCRIPTION:BNT351\, phase 1\, HIV.\nStudy: A Clinical Trial Investigating 
 the Safety and Biological Activity of the Antibody BNT351 in Adults Living
  Without and With HIV\nEstimated primary completion: November 2026. This i
 s a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it ca
 n move.\nDrug page: https://assetmemo.bio/drug/bnt351#upcoming-events\nReg
 istry record: https://clinicaltrials.gov/study/NCT07392372
URL:https://assetmemo.bio/drug/bnt351#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
